Anzeige
Mehr »
Login
Sonntag, 23.03.2025 Börsentäglich über 12.000 News von 693 internationalen Medien
Breaking News: Syntheia meldet extremes User Wachstum: 10.000!!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40HU3 | ISIN: US3207033099 | Ticker-Symbol:
NASDAQ
21.03.25
20:31 Uhr
0,750 US-Dollar
-0,050
-6,25 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
CALIDI BIOTHERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
CALIDI BIOTHERAPEUTICS INC 5-Tage-Chart

Aktuelle News zur CALIDI BIOTHERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14.03.RedChip Companies, Inc.: Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV195ORLANDO, FL / ACCESS Newswire / March 14, 2025 / RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) and Calidi Biotherapeutics, Inc. (NYSE American:CLDI) on the RedChip...
► Artikel lesen
10.03.Calidi Biotherapeutics, Inc. - 8-K, Current Report2
10.03.Calidi Biotherapeutics, Inc: Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform113SAN DIEGO, March 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) ("Calidi"), a clinical-stage biotechnology company developing a new generation of targeted antitumor...
► Artikel lesen
CALIDI BIOTHERAPEUTICS Aktie jetzt für 0€ handeln
28.02.Calidi Biotherapeutics and OS Therapies Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV283ORLANDO, FLORIDA / ACCESS Newswire / February 28, 2025 / RedChip Companies will air interviews with Calidi Biotherapeutics, Inc. (NYSE American:CLDI) and OS Therapies Inc. (NYSE American:OSTX) on the...
► Artikel lesen
24.02.Calidi Biotherapeutics, Inc: Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital63SAN DIEGO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) ("Calidi"), a clinical-stage biotechnology company developing a new generation of targeted antitumor...
► Artikel lesen
29.01.Calidi Biotherapeutics, Inc: Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on February 52
28.01.Calidi Biotherapeutics, Inc: Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement2
28.01.Calidi Biotherapeutics, Inc. - 8-K, Current Report-
10.01.Calidi Biotherapeutics, Inc: Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock1
10.01.Why Calidi Biotherapeutics (CLDI) Stock Is Down 30%1
10.01.Calidi Biotherapeutics slumps 29%, prices $4.25M stock offering2
10.01.Calidi Biotherapeutics, Inc: Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock1
10.01.Calidi Biotherapeutics, Inc. - 8-K, Current Report-
08.01.Calidi Biotherapeutics announces proposed public offering3
08.01.Calidi Biotherapeutics, Inc: Calidi Biotherapeutics Announces Proposed Public Offering2
19.12.24Calidi Biotherapeutics CEO Allan Camaisa verkauft Aktien im Wert von 16.200 US-Dollar3
12.12.24Calidi Biotherapeutics prices $7.5M secondary offering1
12.12.24Calidi Biotherapeutics, Inc. - S-1, General form for registration of securities-
15.11.24Calidi Biotherapeutics, Inc: Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock1
14.11.24Calidi Biotherapeutics announces pricing of $7.5M public offering of common stock2
Seite:  Weiter >>
50 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1